公司概覽
業務類別 Biotechnology
業務概覽 Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
公司地址 465 North Halstead Street, Suite 200, Pasadena, CA, USA, 91107
電話號碼 +1 626 305-5900
傳真號碼 --
公司網頁 https://www.xencor.com
員工數量 260
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. John R. Desjarlais, PhD Executive Vice President, Research and Chief Scientific Officer 美元 547.90K 27/04/2026
Dr. Bassil I. Dahiyat, PhD. Director, President and Chief Executive Officer 美元 742.80K 27/04/2026
Ms. Celia E. Eckert Senior Vice President, General Counsel and Corporate Secretary 美元 491.60K 27/04/2026
Mr. Bart Jan Cornelissen Senior Vice President, Principal Accounting Officer and Chief Financial Officer 美元 491.60K 27/04/2026
 
董事會成員
董事會 職務 更新日期
Dr. A. Bruce Montgomery, M.D. Lead Independent Director 27/04/2026
Dr. Kevin C. Gorman,PhD Independent Director 27/04/2026
Mr. Richard J. Ranieri Independent Director 27/04/2026
Mr. Todd E. Simpson Independent Director 27/04/2026
Mr. Kurt A. Gustafson Independent Director 27/04/2026
Dr. Bassil I. Dahiyat, PhD. Director, President and Chief Executive Officer 27/04/2026
Dr. Barbara Klencke, M.D. Independent Director 27/04/2026
Dr. Ellen G. Feigal, M.D. Independent Director 27/04/2026
Dr. Raymond J. Deshaies, PhD Independent Director 27/04/2026
 
所屬ETF (更新日期: 14/11/2026 04:06)
代號 名稱 佔比% ▼ 持有日期
BIBProShares Ultra Nasdaq Biotechnology0.004%30/10/2026
WSMLiShares MSCI World Small-Cap ETF0.004%30/10/2026
DFSUDimensional US Sustainability Core 1 ETF0.003%30/10/2026
TILTNorthern Trust Mstar US Mkt Fac Tlt ETF0.003%30/10/2026
UWMProShares Ultra Russell20000.003%30/10/2026
MSMLiShares MSCI USA Small-Cap ETF0.003%30/10/2026
WDNAWisdomTree BioRevolution ETF0.003%30/10/2026
AVSUAvantis Responsible US Equity ETF0.001%30/10/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.001%30/10/2026
SAAProShares Ultra SmallCap6000.001%30/10/2026
KBFRInnovator U.S. Small Cap Mgd 10 Bfr ETF0.001%30/10/2026
DXUVDimensional US Vector Equity ETF0.001%24/09/2026
PWSPacer WealthShield ETF0.0005%30/10/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0004%31/05/2023
AVTMAvantis Total Equity Markets ETF0.0004%30/10/2026
PLTLPrincipal US Small-Cap Adptv Mlt-Fac ETF0.0004%30/09/2023
FSEVFidelity Enhanced Small Cap Value ETF0.0002%30/10/2026
RESMColumbia Research Enhanced Small Cap ETF0.0002%31/10/2026
HDGProShares Hedge Replication0.0001%30/10/2026
RBProshares Russell 2000 Dynamic BufferETF0.00003%30/10/2026
  1    2    3   4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.